Catalyst Wire Dossier Catalyst Wire Dossier

ACULAR LS

Ketorolac tromethamine · Allergan, Inc.
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for ACULAR LS, covering 2006-07-04 to 2021-03-05. Get the full timeline:

Most recent: FDA Approved: ACULAR LS — Supplemental Application (Allergan, Inc.)

See pricing